QT9 Software Announces New Global Headquarters in Historic Downtown Batavia

Adaptive reuse project will transform century-old factory into modern tech campus

Huateng Pharma to Showcase High-Purity PEG Derivatives and CDMO Services at CPHI Japan 2026

Huateng Pharma (Hunan Huateng Pharmaceutical Co., Ltd.), a leading manufacturer of high-purity PEG derivatives, pharmaceutical intermediates and fine chemicals, today announced its participation in CPHI Japan 2026. The event will take place from April 21 to April 23 at Tokyo Big Sight.

Multi-Arm PEG Architectures Expand Options for Long-Acting Biologic Development

Biopharma PEG highlights high-purity multi-arm PEG reagents designed to support PEGylation research and therapeutic conjugation development

Lab Thread launches free version of Unified Lab Software Platform to accelerate academic research

Silverstone, UK, 16 March 2026: Lab Thread Ltd, a UK‐based life science software company, today announced the release of a free of charge version of the Company’s Unified Lab Software Platform, available to academic and non-profit researchers worldwide. The software provides a range of core modules tailored to support early-stage research – offering an intuitive and collaborative system that enables users to quickly and easily implement robust data management plans within their own lab.

START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe

This partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research.

Arctoris Launches Biophysics Centre of Excellence to Bridge the AI-Experimentation Gap in Drug Discovery

Arctoris has launched a Biophysics Centre of Excellence featuring a tenfold expansion of biophysical instrumentation, including exclusive early access to the autonomous Instromeda SPRneo platform, to meet growing demand for high-quality experimental data in AI-driven drug discovery. The Centre also formalises strategic partnerships with Instromeda and SPRNexus, and welcomes internationally recognised biophysics expert Dr Iva Navratilova as Expert in Residence, establishing Arctoris as a global reference site for quantitative molecular interaction science at industrial scale.

DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science

DoseMe, a global leader in model-informed precision dosing (MIPD) software, today announced the appointment of Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. In this role, Malone will lead the company’s clinical and scientific initiatives, including oversight of biostatistics, clinical content development, and alignment of scientific strategy with DoseMe’s broader growth objectives, including integration of newly acquired capabilities from Firstline.

ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026

• Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May • Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

LabConnect has officially opened a new central laboratory facility in Wuxi, China, developed in collaboration with Teddy Laboratory (Frontage Laboratories). The site integrates into LabConnect’s global infrastructure to provide unified data, custom kit building, and biorepository services for multi-regional clinical trials. This expansion brings the company to eight global locations, supporting both multinational firms entering China and Asia-Pacific organizations expanding their research internationally.

Baylor Genetics Enhances Whole Genome Sequencing Test with Optical Genome Mapping and Long‑Read Sequencing as Supplemental Technologies

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of clinically relevant genetic testing, today announced enhancements to its Whole Genome Sequencing (WGS) test with the addition of optical genome mapping (OGM) and long‑read sequencing (LRS) as supplemental technologies. These advanced technologies — along with RNA sequencing — enable the company’s WGS test to go beyond standard sequencing approaches, providing a more precise view of a patient’s genome and delivering more answers to help guide patient care and outcomes.

University of Colorado Grants License to Cirena for RNA-Synthesis Technology

Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology.

Abselion Establishes US Subsidiary in Cambridge, MA

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform

Neuland to open commercial peptide facility as part of planned phased expansion

Third Annual Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston May 19

Cambridge Healthtech Institute today announced the agenda for the third annual Bio-IT World Venture, Innovation & Partnering Conference, an exclusive gathering of more than 200 senior-level investors, corporate executives, entrepreneurs and startups, with a focus on connecting capital, technology, and science to accelerate drug discovery.

More Than Half of GLP-1 Users Reported Seeking Follow-Up Care for Side Effects, Phenomix Sciences Report Finds

In conjunction with Obesity Care Week, a national survey from Phenomix Sciences among medication-experienced patients found that GLP-1 outcomes, tolerability, and downstream care needs vary widely, reinforcing the need for more individualized obesity care. Real-world response varies: Many GLP-1 users reported variability in outcomes, including weight-loss plateaus, limited response, or weight gain. Care and costs often extend beyond the prescription: More than half of users required medical care to manage side effects, with some reporting significant out-of-pocket costs. One-size-fits-all falls short: The findings highlight that obesity treatment outcomes differ widely, reinforcing the need for more individualized approaches to care.

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.

Thermo Fisher Scientific Opens Bay Area Cryo-EM Drug Discovery Center to Accelerate Breakthrough Therapies

Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center (CDDC) in South San Francisco. The new center provides pharmaceutical and biotechnology innovators with immersive, hands-on access to advanced cryo-EM technologies designed to accelerate structural insights and the development of life-saving therapies.

Ardena Appoints Paul Edwards as Chief People Officer

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley

Camgenium Expands NHS Access to Advanced, Risk-Adjusted Clinical Audit Analytics